Therefore, we believe that the regulation of NF-κB is also a feasible way to reverse drug-resistant epilepsy, and this method also provides a clinical basis for the anti-inflammatory treatment of drug-resistant epilepsy. The gene discussed is NFKB1; the disease is epilepsy.